Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1408051 | 0.97 | MAPT (0.46) | MAPTTDP1ACHEHPGDALDH1A1 | |
| SCHEMBL2683360 | 0.84 | TDP1 (0.57) | MAPTTDP1ACHEHPGDALDH1A1 | |
| SCHEMBL1992477 | 0.80 | MAPT (0.46) | MAPTTDP1ACHEHPGDALDH1A1 | |
| Hydrochloric Acid SCHEMBL7808105 | 0.78 | MAPT (0.44) | MAPTTDP1ACHEHPGDALDH1A1 | |
| SCHEMBL19104218 | 0.77 | GAA (0.48) | MAPTTDP1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL44533 | 0.75 | — | — | |
| SCHEMBL1758402 | 0.74 | ALDH1A1 (0.46) | TDP1ALDH1A1CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL21465958 | 0.74 | HPGD (0.71) | MAPTTDP1ACHEHPGDALDH1A1 | |
| SCHEMBL2137903 | 0.74 | MAPT (0.46) | MAPTTDP1ACHEHPGDALDH1A1 | |
| SCHEMBL10495949 | 0.74 | ALDH1A1 (0.50) | MAPTTDP1ACHEHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105503939-B | O-methoxy phenylhydrazone double-core titanium complex and its preparation method and application | 山西大学 | 2017-12-05 | — | — | CN | claimed |
| CN-105503939-A | O-methoxy phenylhydrazone dicaryon metal complex and preparation method and application thereof | UNIV SHANXI | 2016-04-20 | — | — | CN | claimed |
| WO-2026100491-A1 | EPOXY RESIN COMPOSITION, CURED OBJECT, UNDERFILL MATERIAL, ADHESIVE, AND SEMICONDUCTOR PACKAGE AND PRODUCTION METHOD THEREFOR | 旭化成株式会社 | 2026-05-15 | — | — | WO | disclosed |
| WO-2026100487-A1 | UNDERFILL MATERIAL, CURED PRODUCT, SEMICONDUCTOR PACKAGE, AND METHOD FOR MANUFACTURING SAME | 旭化成株式会社 | 2026-05-15 | — | — | WO | disclosed |
| WO-2025028605-A1 | CURING AGENT, EPOXY RESIN COMPOSITION, CURED OBJECT, SEALING MATERIAL, AND ADHESIVE | 旭化成株式会社 | 2025-02-06 | — | — | WO | disclosed |
| WO-2025028598-A1 | CURING AGENT FOR EPOXY RESINS, EPOXY RESIN COMPOSITION, CURED OBJECT, SEALING MATERIAL, AND ADHESIVE | 旭化成株式会社 | 2025-02-06 | — | — | WO | disclosed |
| WO-2025028611-A1 | CURING AGENT FOR EPOXY RESINS, EPOXY RESIN COMPOSITION, CURED OBJECT, SEALING MATERIAL, AND ADHESIVE | 旭化成株式会社 | 2025-02-06 | — | — | WO | disclosed |
| US-20250034319-A1 | EPOXY RESIN COMPOSITION, CURED PRODUCT, ENCAPSULANT AND ADHESIVE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-01-30 | — | — | US | disclosed |
| US-20230212132-A1 | AMINIMIDE COMPOUND, AMINIMIDE COMPOSITION, CURING AGENT, EPOXY RESIN COMPOSITION, METHOD FOR PRODUCING AMINIMIDE COMPOUND, ENCAPSULANT, AND ADHESIVE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-07-06 | — | — | US | disclosed |
| WO-2023127800-A1 | EPOXY RESIN COMPOSITION, CURED PRODUCT, SEALING MATERIAL, AND ADHESIVE | 旭化成株式会社 | 2023-07-06 | — | — | WO | disclosed |
| CN-115803323-A | Aminoimide compound, aminimide composition, curing agent, epoxy resin composition, method for producing aminimide compound, sealing material, and adhesive | 旭化成株式会社 | 2023-03-14 | — | — | CN | disclosed |
| CN-1053189-C | pyridazino quinoline compounds | ZENECA LTD (GB) | 2000-06-07 | — | — | CN | disclosed |
| EP-1004582-A2 | Pyridazino quinoline compounds | AstraZeneca UK Limited (GB) | 2000-05-31 | — | — | EP | disclosed |
| US-5744471-A | NERVOUS SYSTEM DISORDERS | ZENECA LIMITED (GB) | 1998-04-28 | — | — | US | disclosed |
| EP-0790996-A1 | PYRIDAZINOQUINOLINE COMPOUNDS | ZENECA LIMITED (GB) | 1997-08-27 | — | — | EP | disclosed |
| CN-1156446-A | carbamoyl carbohydrazide | BASF AG (DE) | 1997-08-06 | — | — | CN | disclosed |
| CN-1138332-A | Pyridazinoquinoline compounds | ZENECA LTD (GB) | 1996-12-18 | — | — | CN | disclosed |
| EP-0724583-A1 | PYRIDAZINO QUINOLINE COMPOUNDS | ZENECA LIMITED (GB) | 1996-08-07 | — | — | EP | disclosed |
| WO-1996015127-A1 | PYRIDAZINOQUINOLINE COMPOUNDS | ZENECA LIMITED (GB) | 1996-05-23 | — | — | WO | disclosed |
| WO-1995011244-A1 | PYRIDAZINO QUINOLINE COMPOUNDS | ZENECA LIMITED (GB) | 1995-04-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212132-A1 | AMINIMIDE COMPOUND, AMINIMIDE COMPOSITION, CURING AGENT, EPOXY RESIN COMPOSITION, METHOD FOR PRODUCING AMINIMIDE COMPOUND, ENCAPSULANT, AND ADHESIVE | ITGAL, VCL, RPL39 | MAPT 2289/4885TDP1 4248/4885ACHE 2074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.